Technology
Health
Biotechnology

Dyadic International

$6.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.52 (-7.77%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell DYAI and other stocks, options, ETFs, and crypto commission-free!

About

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. Read More The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL. DYAI is listed on the OTCQX U.S. Premier market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
8
Headquarters
Jupiter, Florida
Founded
1979
Market Cap
178.71M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
65.13K
High Today
$6.69
Low Today
$6.16
Open Price
$6.69
Volume
312.33K
52 Week High
$7.30
52 Week Low
$1.40

Collections

Technology
Health
Biotechnology
2019 IPO
US
North America

Earnings

-$0.08
-$0.05
-$0.03
$0.00
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.